TARGET SPECIES: Cattle (calves), sheep, goats, pigs, dogs, cats.
INDICATIONS: Calves:
The treatment of respiratory tract infections caused by enrofloxacin-sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Mycoplasma spp. The treatment of digestive tract infections caused by enrofloxacin-sensitive strains of Escherichia coli. The treatment of sepsis caused by enrofloxacin-sensitive strains of Escherichia coli. The treatment of arthritis associated with acute mycoplasmosis caused by enrofloxacin-sensitive strains of Mycoplasma bovis.
Sheep:
The treatment of digestive tract infections caused by enrofloxacin-sensitive strains of Escherichia coli. The treatment of sepsis caused by enrofloxacin-sensitive strains of Escherichia coli. The treatment of mastitis caused by enrofloxacin-sensitive strains of Staphylococcus aureus and Escherichia coli.
Goats:
The treatment of respiratory tract infections caused by enrofloxacin-sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Mycoplasma spp. The treatment of digestive tract infections caused by enrofloxacin-sensitive strains of Escherichia coli. The treatment of sepsis caused by enrofloxacin-sensitive strains of Escherichia coli. The treatment of mastitis caused by enrofloxacin-sensitive strains of Staphylococcus aureus and Escherichia coli.
Pigs:
The treatment of respiratory tract infections caused by enrofloxacin-sensitive strains of Pasteurella multocida, Mycoplasma spp. and Actinobacillus pleuropneumoniae. The treatment of digestive tract infections caused by enrofloxacin-sensitive strains of Escherichia coli. The treatment of sepsis caused by enrofloxacin-sensitive strains of Escherichia coli.
Dogs:
The treatment of digestive, respiratory and urogenital tract infections (including prostatitis, adjuvant therapy with antibiotics for pyometra), skin infections and wounds, otitis (external/medium), caused by enrofloxacin-sensitive strains of: Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp. and Proteus spp.
Cats:
The treatment of digestive, respiratory and urogenital tract infections (as adjunctive therapy with antibiotics for pyometra), skin infections and wounds, caused by enrofloxacin-sensitive strains of: Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp. and Proteus spp.
1 ml of solution for injection contains:
Enrofloxacin……………………………………………………..50 mg
CONTRAINDICATIONS:
Do not administer in case of hypersensitivity to the active substance or any of the excipients. Do not administer to dogs with a history of epilepsy. Do not administer to dogs under the age of 8 months (small ones), under 12 months (medium-sized ones) and 18 months (large ones).
Do not use it in cats under 8 weeks of age. Do not use it in growing horses because it can cause possible conditions of the articular cartilage.
ADVERSE REACTIONS:
Occasionally, in some animals, there may be recorded: hives, gastrointestinal disorders (vomiting, diarrhea). Very rarely, the product can cause some behavioral changes (restlessness). Young animals treated with enrofloxacin may suffer joint cartilage damage. Transient edema may occur at the site of inoculation. If you notice any serious reactions or other effects not listed in this leaflet, please inform your veterinarian.
METHOD OF ADMINISTRATION:
Administer it intravenously, subcutaneously or intramuscularly.
Repeated injections should be performed at different injection sites.
Calves:
5 mg of enrofloxacin/kg bw, which corresponds to 1 ml/10 kg bw, once daily, for 3-5 days. Arthritis associated with acute mycoplasmosis caused by enrofloxacin-sensitive strains of Mycoplasma bovis: 5 mg of enrofloxacin/kg bw, which corresponds to 1 ml/10 kg bw, once daily, for 5 days. The product may be administered by slow intravenous injection or subcutaneously. No more than 10 ml should be administered in a single subcutaneous injection site.
Sheep and goats:
5 mg of enrofloxacin/kg bw, which corresponds to 1 ml/10 kg bw, once daily, by subcutaneous injection, for 3 days. No more than 6 ml should be administered in a single subcutaneous injection site.
Pigs:
2.5 mg of enrofloxacin/kg bw, which corresponds to 0.5 ml/10 kg bw, once daily, by intramuscular injection, for 3 days. Infections of the digestive tract or sepsis caused by Escherichia coli: 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily, by intramuscular injection, for 3 days. In pigs, the injection should be done in the neck, at the base of the ear. No more than 3 ml should be administered in a single intramuscular injection site.
Dogs and cats:
5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, daily, by subcutaneous injection, up to 5 days.
Treatment can be started with the product for injection and can be maintained with enrofloxacin tablets. The duration of treatment should be based on the duration of the approved treatment for the appropriate indication in the compressed product information.
RECOMMENDATIONS FOR PROPER ADMINISTRATION:
In order to ensure proper dosage, the body weight (bw) of the animals should be determined as accurately as possible to avoid under-dosing.
WITHDRAWAL PERIOD:
Calves:
After the intravenous injection: meat and offal: 5 days.
After the subcutaneous injection: meat and offal: 12 days.
It is not authorized for use in animals producing milk for human consumption.
Sheep:
Meat and offal: 4 days.
Milk: 3 days.
Goats:
Meat and offal: 6 days.
Milk: 4 days.
Pigs:
Meat and offal: 13 days.
PRECAUTIONS AND SPECIAL INDICATIONS}
STORAGE:
Keep out of the reach and sight of children. Store at temperatures lower than 25°C. Keep away from direct sunlight and frost. Keep in a dry place. Do not use after the product expiration date stated on the label. Shelf life after first opening the primary packaging: 28 days.
PRESENTATION}